Premier Allergy Premier Allergy and Asthma is a company operating as a medical clinic that diagnoses and treats patients of all ages for allergies, asthma, and other conditions. | ![]() Bioventix Bioventix is a biotechnology company specializing in the development of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drug of abuse testing. | ![]() Alere Alere (formerly known as Inverness Medical Innovations) is a company that provides diagnostics and health management solutions for infectious, heart, and cancer-related diseases and drug addicts. | ![]() Actinium Pharmaceuticals Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers. | ![]() Medgenome Labs MedGenome is a genomics-based diagnostics and research company developing healthcare solutions by decoding genetic information contained in an individual's genome. | |
Founding Date | Founding Date N/A | Founding Date 2003 | Founding Date 1981 | Founding Date 2000 | Founding Date 2013 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Dublin, US HQ | Locations Farnham, GB HQ | Locations New York, US HQ | Locations Foster City, US HQ Bengaluru, IN Bengaluru, IN Wilmington, US | |
Employees | Employees 325% decrease | Employees 17 | Employees 1,8642% decrease | Employees 2517% decrease | Employees 8872% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 251.1 m | Valuation ($) N/A | Valuation ($) 58.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £13.1m (FY, 2025) | Revenue (est.) $2.4b (FY, 2016) | Revenue (est.) $90k (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods £1.1m (FY, 2025) | Cost of goods $1.3b (FY, 2016) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit £12m (FY, 2025) | Gross profit $1.1b (FY, 2016) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income £7.6m (FY, 2025) | Net income ($137.6m) (FY, 2016) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7m | Total funding raised $ 119m |

Bioventix is a biotechnology company specializing in the development of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drug of abuse testing.
View company
Alere (formerly known as Inverness Medical Innovations) is a company that provides diagnostics and health management solutions for infectious, heart, and cancer-related diseases and drug addicts.
View company
Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers.
View company
MedGenome is a genomics-based diagnostics and research company developing healthcare solutions by decoding genetic information contained in an individual's genome.
View company